Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Farnaz Zahedifard

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Plos Neglected Tropical Diseases|March 29, 2014
Enhanced protective efficacy of nonpathogenic recombinant leishmania tarentolae expressing cysteine proteinases combined with a sand fly salivary antigenFarnaz Zahedifard, Elham Gholami, Tahereh Taheri, et al.
Plos One|July 22, 2015
Evaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against Experimental Canine Visceral LeishmaniasisMehdi Shahbazi, Farnaz Zahedifard, Tahereh Taheri, et al.
Nature Communications|April 27, 2023
Cryo-EM structures of Trypanosoma brucei gambiense ISG65 with human complement C3 and C3b and their roles in alternative pathway restrictionHagen Sülzen, Jakub Began, Arun Dhillon, et al.
Plos Neglected Tropical Diseases|September 13, 2011
In silico analysis of six known Leishmania major antigens and in vitro evaluation of specific epitopes eliciting HLA-A2 restricted CD8 T cell responseNegar Seyed, Farnaz Zahedifard, Shima Safaiyan, et al.
Plos Neglected Tropical Diseases|May 3, 2013
Development of novel prime-boost strategies based on a tri-gene fusion recombinant L. tarentolae vaccine against experimental murine visceral leishmaniasisNoushin Saljoughian, Tahereh Taheri, Farnaz Zahedifard, et al.
The Journal of Biological Chemistry|November 21, 2022
Impact of inherent biases built into proteomic techniques: Proximity labeling and affinity capture comparedClaudia Maria do Nascimento Moreira, Cristina D Kelemen, Samson O Obado, et al.
Scientific Reports|October 2, 2020
Molecular signatures of anthroponotic cutaneous leishmaniasis in the lesions of patients infected with Leishmania tropicaNasrin Masoudzadeh, Malin Östensson, Josefine Persson, et al.
Antimicrobial Agents and Chemotherapy|July 20, 2022
Repurposing of MitoTam: Novel Anti-Cancer Drug Candidate Exhibits Potent Activity against Major Protozoan and Fungal PathogensDominik Arbon, Kateřina Ženíšková, Karolína Šubrtová, et al.
ACS Infectious Diseases|December 22, 2025
Modular Design of Mitochondrion-Targeted Iron Chelators Allows Highly Selective Antiparasitic Activity against Trypanosomes and Apicomplexan ParasitesRonald Malych, Yann Bordat, Kristýna Klanicová, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Plos Neglected Tropical Diseases|March 29, 2014
Enhanced protective efficacy of nonpathogenic recombinant leishmania tarentolae expressing cysteine proteinases combined with a sand fly salivary antigenFarnaz Zahedifard, Elham Gholami, Tahereh Taheri, et al.
Plos One|July 22, 2015
Evaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against Experimental Canine Visceral LeishmaniasisMehdi Shahbazi, Farnaz Zahedifard, Tahereh Taheri, et al.
Nature Communications|April 27, 2023
Cryo-EM structures of Trypanosoma brucei gambiense ISG65 with human complement C3 and C3b and their roles in alternative pathway restrictionHagen Sülzen, Jakub Began, Arun Dhillon, et al.
Plos Neglected Tropical Diseases|September 13, 2011
In silico analysis of six known Leishmania major antigens and in vitro evaluation of specific epitopes eliciting HLA-A2 restricted CD8 T cell responseNegar Seyed, Farnaz Zahedifard, Shima Safaiyan, et al.
Plos Neglected Tropical Diseases|May 3, 2013
Development of novel prime-boost strategies based on a tri-gene fusion recombinant L. tarentolae vaccine against experimental murine visceral leishmaniasisNoushin Saljoughian, Tahereh Taheri, Farnaz Zahedifard, et al.
The Journal of Biological Chemistry|November 21, 2022
Impact of inherent biases built into proteomic techniques: Proximity labeling and affinity capture comparedClaudia Maria do Nascimento Moreira, Cristina D Kelemen, Samson O Obado, et al.
Scientific Reports|October 2, 2020
Molecular signatures of anthroponotic cutaneous leishmaniasis in the lesions of patients infected with Leishmania tropicaNasrin Masoudzadeh, Malin Östensson, Josefine Persson, et al.
Antimicrobial Agents and Chemotherapy|July 20, 2022
Repurposing of MitoTam: Novel Anti-Cancer Drug Candidate Exhibits Potent Activity against Major Protozoan and Fungal PathogensDominik Arbon, Kateřina Ženíšková, Karolína Šubrtová, et al.
ACS Infectious Diseases|December 22, 2025
Modular Design of Mitochondrion-Targeted Iron Chelators Allows Highly Selective Antiparasitic Activity against Trypanosomes and Apicomplexan ParasitesRonald Malych, Yann Bordat, Kristýna Klanicová, et al.
Pageof 5